Crossmark

Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor

Crossref DOI link: https://doi.org/10.1038/s43018-023-00583-2

Published Online: 2023-06-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Silva, Jose https://orcid.org/0000-0001-5147-8950
Yu, Jiyang https://orcid.org/0000-0003-3629-4330
Kalinsky, Kevin https://orcid.org/0000-0002-3113-7902
License Information

Text and Data Mining valid from 2023-06-15

Version of Record valid from 2023-06-15
More Information

Article History

Received: 13 February 2023

Accepted: 17 May 2023

First Online: 15 June 2023

Competing interests

: The authors declare no competing interests.